Order Article Reprints

Mitkin NA, Pavshintcev VV, Sukhanova IA, Doronin II, Babkin GA, Sadagurski M, Malyshev AV. The Novel Peptide Chm-273s Has Therapeutic Potential for Metabolic Disorders: Evidence from In Vitro Studies and High-Sucrose Diet and High-Fat Diet Rodent Models. Pharmaceutics. 2022; 14(10):2088. https://doi.org/10.3390/pharmaceutics14102088

Mitkin, Nikita A., Vsevolod V. Pavshintcev, Iuliia A. Sukhanova, Igor I. Doronin, Gennady A. Babkin, Marianna Sadagurski, and Anton V. Malyshev. 2022. "The Novel Peptide Chm-273s Has Therapeutic Potential for Metabolic Disorders: Evidence from In Vitro Studies and High-Sucrose Diet and High-Fat Diet Rodent Models" Pharmaceutics 14, no. 10: 2088. https://doi.org/10.3390/pharmaceutics14102088

Mitkin, N. A., Pavshintcev, V. V., Sukhanova, I. A., Doronin, I. I., Babkin, G. A., Sadagurski, M., & Malyshev, A. V. (2022). The Novel Peptide Chm-273s Has Therapeutic Potential for Metabolic Disorders: Evidence from In Vitro Studies and High-Sucrose Diet and High-Fat Diet Rodent Models. Pharmaceutics, 14(10), 2088. https://doi.org/10.3390/pharmaceutics14102088